102940.KQ | Kolon Life Science Inc. Annual & Quarterly

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019
Total Assets	309.43 Billion	314.11 Billion	234.65 Billion	248.33 Billion	278.29 Billion
Total Current Assets	105.04 Billion	110.18 Billion	98.02 Billion	100.56 Billion	15 Billion
Cash And Short Term Investments	7.56 Billion	6.37 Billion	27.91 Billion	15.03 Billion	15 Billion
Cash and Cash Equivalents	7.56 Billion	6.37 Billion	27.8 Billion	15 Billion	5.91 Billion
Short Term Investments	-	-	110 Million	30 Million	15 Billion
Net Receivables	29.7 Billion	35.31 Billion	24.11 Billion	42.74 Billion	28.52 Billion
Inventory	67.77 Billion	68.49 Billion	45.99 Billion	42.79 Billion	36.06 Billion
Other Current Assets	600.00	960.00	120.00	-670.00	5.65 Billion
Total Non-Current Assets	204.39 Billion	203.93 Billion	136.63 Billion	147.77 Billion	1.21 Billion
Net PPE	123.13 Billion	125.96 Billion	131.48 Billion	141.89 Billion	178.39 Billion
Good Will And Intangible Assets	332.53 Million	1.55 Billion	1.71 Billion	1.93 Billion	1.21 Billion
Good Will	-	1.21 Billion	1.21 Billion	1.21 Billion	1.21 Billion
Intangible Assets	332.53 Million	342.59 Million	502.14 Million	722.22 Million	258.56 Million
Long-Term Investments	77.05 Billion	75.24 Billion	2.43 Billion	3.23 Billion	2.14 Billion
Tax Assets	-77.05 Billion	-75.24 Billion	998.53 Million	-	-179.32 Billion
Other Non Current Assets	80.92 Billion	76.41 Billion	10.00	710.56 Million	-1.21 Billion
Other Assets	-	10.00	10.00	-	262.07 Billion
Total Liabilities	171.76 Billion	146.39 Billion	135.24 Billion	190.38 Billion	177.27 Billion
Total Current Liabilities	128.34 Billion	109.57 Billion	95.46 Billion	145.15 Billion	126.17 Billion
Account Payables	11.54 Billion	17.04 Billion	13.77 Billion	11.8 Billion	10.71 Billion
Tax Payables	-	376.35 Million	-	-	-
Short Term Debt	97.69 Billion	73.74 Billion	64.73 Billion	67.43 Billion	60.26 Billion
Deferred Revenue	19.1 Billion	18.77 Billion	16.96 Billion	65.91 Billion	-
Other Current Liabilities	250.00	-220.00	560.00	100.00	55.19 Billion
Total Non Current Liabilities	43.42 Billion	36.81 Billion	39.77 Billion	45.22 Billion	51.1 Billion
Long-Term Debt	10.17 Billion	167.18 Million	4.19 Billion	9.59 Billion	18.23 Billion
Deferred Revenue Non Current	4.44 Billion	3.44 Billion	3.44 Billion	3.44 Billion	-
Deferred Tax Liabilities Non Current	-	-	-	-	-
Other Non Current Liabilities	18.92 Billion	23.44 Billion	10.00	-400.00	32.86 Billion
Other Liabilities	-	-	-	10.00	-
Total Equity	137.67 Billion	167.72 Billion	99.41 Billion	57.95 Billion	101.02 Billion
Stock Holders Equity	137.67 Billion	167.72 Billion	99.41 Billion	57.95 Billion	101.02 Billion
Common Stock	5.7 Billion	5.7 Billion	5.7 Billion	5.7 Billion	5.7 Billion
Retained Earnings	-133.28 Billion	-101.53 Billion	-106.02 Billion	-104.35 Billion	-61.36 Billion
Accumulated other comprehensive income	56.14 Billion	54.44 Billion	-9 Billion	-10.55 Billion	-10.49 Billion
Common Stock Equity	137.67 Billion	167.72 Billion	99.41 Billion	57.95 Billion	101.02 Billion
Capital Lease Obligation	619.99 Million	454.8 Million	527.47 Million	610.79 Million	375.58 Million
Total Investments	77.05 Billion	75.24 Billion	2.54 Billion	3.26 Billion	15 Billion
Total Debt	107.86 Billion	73.91 Billion	68.92 Billion	77.02 Billion	78.5 Billion
Net Debt	100.3 Billion	67.54 Billion	41.12 Billion	62.02 Billion	72.58 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	356.35 Billion	350.7 Billion	309.43 Billion	309.43 Billion	314.82 Billion	330.42 Billion
Total Current Assets	114.18 Billion	113.56 Billion	105.04 Billion	105.04 Billion	109.07 Billion	121.08 Billion
Cash And Short Term Investments	25.56 Billion	8.38 Billion	7.56 Billion	7.56 Billion	11.41 Billion	26.04 Billion
Cash and Cash Equivalents	25.56 Billion	8.38 Billion	7.56 Billion	7.56 Billion	11.41 Billion	26.04 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	33.66 Billion	31.42 Billion	29.7 Billion	29.7 Billion	26.92 Billion	28.79 Billion
Inventory	49.05 Billion	67.23 Billion	67.77 Billion	67.77 Billion	70.74 Billion	66.24 Billion
Other Current Assets	2.19 Billion	6.51 Billion	600.00	600.00	249.54 Thousand	70.00
Total Non-Current Assets	242.16 Billion	237.13 Billion	204.39 Billion	204.39 Billion	205.74 Billion	209.33 Billion
Net PPE	118.84 Billion	123.21 Billion	123.13 Billion	123.13 Billion	128.38 Billion	127.05 Billion
Good Will And Intangible Assets	516.6 Million	163.46 Million	332.53 Million	332.53 Million	318.11 Million	273.4 Million
Good Will	-	-	-	-	-	-
Intangible Assets	516.6 Million	163.46 Million	332.53 Million	332.53 Million	318.11 Million	273.4 Million
Long-Term Investments	119.07 Billion	109.97 Billion	77.05 Billion	77.05 Billion	75.62 Billion	80.63 Billion
Tax Assets	-450.00	-120.00	-77.05 Billion	-77.05 Billion	-75.62 Billion	-80.63 Billion
Other Non Current Assets	3.73 Billion	3.78 Billion	80.92 Billion	80.92 Billion	77.04 Billion	82 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	228.58 Billion	191.01 Billion	171.76 Billion	171.76 Billion	164.17 Billion	168.77 Billion
Total Current Liabilities	183.04 Billion	141.05 Billion	128.34 Billion	128.34 Billion	116.24 Billion	126.48 Billion
Account Payables	11.81 Billion	12.98 Billion	11.54 Billion	11.54 Billion	10.78 Billion	10.72 Billion
Tax Payables	-	-	-	-	-	-
Short Term Debt	119.39 Billion	112.75 Billion	97.69 Billion	97.69 Billion	88.14 Billion	99.52 Billion
Deferred Revenue	7.19 Billion	500.00	19.1 Billion	19.1 Billion	17.31 Billion	16.23 Billion
Other Current Liabilities	44.62 Billion	15.3 Billion	250.00	250.00	530.00	710.00
Total Non Current Liabilities	45.54 Billion	49.95 Billion	43.42 Billion	43.42 Billion	47.92 Billion	42.29 Billion
Long-Term Debt	4.99 Billion	10.22 Billion	10.17 Billion	10.17 Billion	10.23 Billion	5.31 Billion
Deferred Revenue Non Current	-	4.44 Billion	4.44 Billion	4.44 Billion	4.44 Billion	4.44 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	40.55 Billion	19.11 Billion	18.92 Billion	18.92 Billion	23.4 Billion	21.64 Billion
Other Liabilities	-	-	-	-	10.00	-
Total Equity	127.77 Billion	159.69 Billion	137.67 Billion	137.67 Billion	150.65 Billion	161.64 Billion
Stock Holders Equity	127.77 Billion	159.69 Billion	137.67 Billion	137.67 Billion	150.65 Billion	161.64 Billion
Common Stock	6.16 Billion	5.7 Billion	5.7 Billion	5.7 Billion	5.7 Billion	5.7 Billion
Retained Earnings	-197.22 Billion	-137.89 Billion	-133.28 Billion	-133.28 Billion	-118.91 Billion	-111.88 Billion
Accumulated other comprehensive income	90.18 Billion	82.76 Billion	56.14 Billion	56.14 Billion	54.74 Billion	58.7 Billion
Common Stock Equity	127.77 Billion	159.69 Billion	137.67 Billion	137.67 Billion	150.65 Billion	161.64 Billion
Capital Lease Obligation	708.88 Million	771.85 Million	619.99 Million	619.99 Million	827.01 Million	1.01 Billion
Total Investments	119.07 Billion	109.97 Billion	77.05 Billion	77.05 Billion	75.62 Billion	80.63 Billion
Total Debt	124.38 Billion	122.97 Billion	107.86 Billion	107.86 Billion	98.37 Billion	104.83 Billion
Net Debt	98.82 Billion	114.59 Billion	100.3 Billion	100.3 Billion	86.96 Billion	78.79 Billion

Balance Sheet Charts

Integra LifeSciences Holdings Corporation

IART

Full Analysis

Annual Balance Sheets
Cementos Pacasmayo S.A.A.

CPAC

Full Analysis

Annual Balance Sheets
CINC Corp.

4378

Full Analysis

Annual Balance Sheets
Talis Biomedical Corporation

TLIS

Full Analysis

Annual Balance Sheets
Shokubun Co., Ltd.

9969

Full Analysis

Annual Balance Sheets
SinoMedia Holding Limited

0623

Full Analysis

Annual Balance Sheets

Global Stocks Search

Kolon Life Science Inc. (102940.KQ)

Annual Balance Sheets

Balance Sheet Charts

Integra LifeSciences Holdings Corporation

Cementos Pacasmayo S.A.A.

CINC Corp.

Talis Biomedical Corporation

Shokubun Co., Ltd.

SinoMedia Holding Limited